PREOPERATIVE CONCURRENT CBDCA CHEMOTHERAPY AND ACCELERATED HYPERFRACTIONATED RADIOTHERAPY FOR SQUAMOUS CELL CARCINOMA OF THE MAXILLARY REGION
Ken Omura(Ebina General Hospital), Takashi Togawa(Chiba Cancer Center), Hiroyuki Harada(Tokyo Medical and Dental University), Kazuo Hatano(Astellas Pharma (Japan)), Yosuke Takeuchi(Chiba Cancer Center), Haruhiko Suzuki(Tohoku University)
Cited by 3
Related Papers
Exploration of Tumor-Suppressive MicroRNAs Silenced by DNA Hypermethylation in Oral Cancer
|Cancer Research|2008|618
Current status of oral cancer treatment strategies: surgical treatments for oral squamous cell carcinoma
|International Journal of Clinical Oncology|2014|263
Phase II trial of gefitinib alone without radiation therapy for Japanese patients with brain metastases from EGFR-mutant lung adenocarcinoma
|Lung Cancer|2013|261
The Tumor Suppressive MicroRNA <i>miR-218</i> Targets the mTOR Component <i>Rictor</i> and Inhibits AKT Phosphorylation in Oral Cancer
|Cancer Research|2011|250
Differential binding properties of B7-H1 and B7-DC to programmed death-1
|Biochemical and Biophysical Research Communications|2003|206